Melhores Timoma médicos - TOP-49 médicos

O Dr. Mustafa Solak é um oncologista médico especializado em cânceres de mama, testículo, ovário, pulmão, cabeça-pescoço e gastrointestinal. Ele se formou na Faculdade de Medicina da Universidade de Hacettepe. Completou sua residência no Hospital de Ensino e Pesquisa Sisli Etfal de Istambul. Em seguida, fez uma bolsa de especialização no Instituto de Câncer da Universidade de Hacettepe.

O Dr. Solak geriu muitos casos complexos de câncer. Ele contribuiu para avanços clínicos em centros respeitados, incluindo o MD Anderson Cancer Center da Universidade do Texas. Também trabalhou no Hospital de Treinamento de Hitit University Corum e no Hospital Medical Park. Sua experiência demonstra um forte compromisso com o cuidado e a pesquisa do câncer.

Dr. Ofer Merimsly é o melhor médico em sarcoma, linfoma e câncer de pulmão em Israel e no mundo. Também é especialista no tratamento cirúrgico Whipple para pacientes com câncer de pâncreas. Chefe do Centro Nacional para sarcomas ósseos e de tecidos moles do Centro Médico Tel Aviv Sourasky (Ichilov).

Especialidade:

• Tratamento de todos os tipos de câncer de pulmão e órgãos torácicos
• Tratamento de todos os tipos de sarcomas ósseos e de tecidos moles
• Tratamento de tumores estromais do trato gastrointestinal

Educação e especialização:

• Ensino superior em medicina, formado pela Faculdade de Medicina da Universidade Hebraica de Jerusalém, Israel
• Residência em Oncologia Geral e Radioterapia
• Treinamento em radioterapia e braquiterapia no New York Hospital, EUA
• Curso de atualização especial para o tratamento de tumores do esqueleto e tecidos moles, Paris, França

Membro:

• Presidente da Sociedade de Oncologistas e Radioterapeutas de Israel
• Sociedade Americana de Câncer Científico
• Organização médica científica europeia
• Sociedade Europeia de Oncologia do sistema musculoesquelético
• Sociedade Internacional para o tratamento de tumores do tecido conjuntivo

Um dos melhores especialistas em câncer na Europa, educador e pesquisador de câncer, Presidente do Central European Cooperative Oncology Group (CECOG).
Publicou mais de 600 artigos científicos sobre o tratamento do câncer.

Oncologista, Oncohematologista, Cirurgião

Médico chefe do Centro de Oncologia e Hematologia

A Prof.ª Elke Jaeger é uma das melhores médicas alemãs de acordo com a classificação da Focus.

Education and Specialization

• Faculty of Medicine, Hacettepe University
• 1999 - Akdeniz University, Faculty of Internal Medicine, Internal Medicine Specialization Training
• Internal Medicine Specialization Training in the USA, Akdeniz University (2013 - 2014)
• Internal Medicine Specialization Training in the USA (2013 - 2014) - Medical Oncology Department
• Akdeniz University, Faculty of Medicine, Department of Medical Oncology (Received Associate Professorship title)

Work Experience

• 2009 - Kayseri Training and Research Hospital, Hospital
• Acıbadem Kayseri
• 2017 - 2018 - Lara Private Anadolu Hospital
• 2018 - Medical Park Antalya Hospital Complex

Expertise

• Diagnosis of organ tumors
• Chemotherapy in cancer treatment
• Targeted cancer therapies
• Immunotherapy in cancer treatment
• Next-generation genetic research in cancer treatment
• Complementary medicine in cancer treatment
• Medical oncology

O Professor Ralf Buhl é um neurocirurgião de renome mundial com mais de 20 anos de experiência. O Dr. Buhl lidera o Departamento de Neurocirurgia no Solingen Klinikum. A sua reputação alcança a China e os EUA, onde ministra palestras sobre neurocirurgia.

Especialidade

O Dr. Buhl é especialista em métodos não invasivos para o tratamento de hérnia discal, tumores cerebrais e medulares. O médico oferece tratamento para distúrbios do sistema nervoso periférico e realiza microcirurgias com navegação assistida por computador.

O Dr. Ralf Buhl realizou mais de 4.000 neurocirurgias bem-sucedidas. Entre os seus pacientes estão políticos famosos, empresários, músicos e atores. Em 2015, uma estrela de Hollywood, George Clooney, teve dores intensas nas costas e foi tratado pelo Professor Buhl.

Atividade científica

O Dr. Buhl realiza trabalhos científicos e pesquisas no tratamento de cavernomas intracranianos, tratamento cirúrgico de metástases cerebrais e outras áreas da neurocirurgia.

O Professor Buhl foi cofundador do Fundo dedicado ao estudo de tumores cerebrais.

Personal information

Title: Professor Doctor

Branch: Radiation Oncology

Work History:

1 GATA Military Medical Faculty

2 Gayrettepe Florence Nightingale Hospital

3 T.R. Demiroğlu Bilim University \ Associate Professor

4 T.R Demiroğlu Bilim University \ Professor

Medical Specialties and Subspecialties:

1 Head and Neck Cancers

2 Radiation Oncology

Priority treatments:

1 Prostate cancer

2 Conformal treatments

Special advanced health technologies:

1 Truebeam Stx Technology

2 Halcyons

Education

1991 - Istanbul University Istanbul Faculty of Medicine

1996 - Istanbul University Cerrahpaşa Faculty of Medicine Radiation

Oncology Specialization Training

Experience

2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital

2020 - 2021 Yüzüncü Yıl University Faculty of Medicine

2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.  

2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department  

2018 - 2021 Yüzüncü Yıl University Faculty of Medicine

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant

2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist

2012 - 2015 Suleiman the Magnificent Training and Research Hospital,

2008 - 2012 Haseki Training and Research Hospital

2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.

Education

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2007

Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi

Activities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr  18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery.  • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations 

Education and Expertise

Selcuk University Meram Faculty of Medicine - Medical Education

Dr.Abdurrahman Yurtaslan Anakara Oncology Training and Research Hospital Medical Oncology Specialization

Experience

Malatya State Hospital Internal Diseases Clinic

Ankara Oncology Hospital Medical Oncology Clinic

Erzurum Regional Training and Research Hospital Medical Oncology Clinic


AREAS OF INTEREST

Lung cancer

esophageal cancer

Gastric cancer

breast cancer

Gastrointestinal surgery

https://scholar.google.com.tr/citations?user=EDuylhoAAAAJ&hl=tr 

Professor of oncosurgery and proctology

Univ.-Prof. Dr. Wolfgang Johannes Köstler is a board-certified specialist for Internal Medicine, Hematology/Oncology, and Intensive Care Medicine who specializes in hematology & internal oncology, intensive care medicine. He is one of the top-rated breast cancer and sarcoma oncologist specialists and has extensive experience in the field and has received degrees from the Medical University of Vienna and the Weizmann Institute of Science. He has also had special training at Memorial Sloan-Kettering Cancer Center and Royal Prince Alfred Hospital.

Dr. Felix Dobritoiu is a thoracic surgeon at Ponderas Academic Hospital. He specializes in minimally invasive and robotic procedures for adults and children. He performs robotic thoracic surgery with the da Vinci Xi system. He also uses video-assisted thoracoscopic surgery (VATS), including uniportal VATS. These methods use small incisions for faster recovery.

His practice includes mediastinoscopy and bronchoscopy. He performs complex lung and mediastinal resections. He also offers sternochondroplasty (Nuss and reversed Nuss). In selected cases, he can perform minimally invasive procedures without postoperative pleural drainage.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Inta Jaunalksne is an experienced immunologist with more than 30 years in the field. She specializes in virotherapy. She graduated from Riga Medical Institute and completed an internship in Internal Medicine. Dr. Jaunalksne is recognized as an expert in immunology.

She leads the Clinical Immunology Center at Pauls Stradins Clinical University Hospital. Dr. Jaunalksne has played a key role in advancing virotherapy and immunological research. Her work has improved treatment results and introduced new therapies. She is well respected in clinical immunology.